After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Shockwave Medical Inc. (SWAV) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$2.61, or -1.15%, to $225.00. The Shockwave Medical Inc. has recorded 4,937 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Shockwave Medical to Participate in Upcoming Investor Conferences.
SWAV belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $227.61 and fluctuated between $232.52 as its day high and $225.03 as its day low. The current market capitalization of Shockwave Medical Inc. is $8.29B. A total of 0.55 million shares were traded on the day, compared to an average of 590.79K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, SWAV has seen 11 BUY and 23 SELL insider trades, representing the acquisition of 29,269 and the disposition of 19,338 shares. Over the last 12 months, there were 36 BUYs and 122 SELLs from insiders. Insiders purchased 170,014 shares during that period but sold 218,433.
In the most recent transaction, Zacharias Isaac sold 4,000 shares of SWAV for 204.98 per share on Aug 25. After the transaction, the President, CCO now owns 52,446 company shares. In a previous transaction on Aug 24, Godshall Douglas Evan sold 10,000 shares at 214.62 per share. SWAV shares that President & CEO owns now total 141,649.
Among the insiders who sold shares, FRANCIS LAURA disposed of 497 shares on Aug 22 at a per-share price of $220.97. This resulted in the Director holding 3,054 shares of SWAV after the transaction. In another insider transaction, WATKINS FRANK T sold 3,000 shares at $219.29 per share on Aug 21. Company shares held by the Director now total 1,532.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for SWAV in the last 3 months, the mean price target is $284.89 with high estimates of $330.00 and low estimates of $165.00. In terms of 52-week highs and lows, SWAV has a high of $320.54 and a low of $172.50.
As of this writing, SWAV has an earnings estimate of $0.77 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $0.93 per share and a lower estimate of $0.64. The company reported an EPS of $1.03 in the last quarter, which was 27.20% higher than expectations of $0.81.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SWAV’s latest balance sheet shows that the firm has $200.98M in Cash & Short Term Investments as of fiscal 2021. There were $47.19M in debt and $51.63M in liabilities at the time. Its Book Value Per Share was $16.83, while its Total Shareholder’s Equity was $241.83M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SWAV is Buy with a score of 4.00.